Related references
Note: Only part of the references are listed.CTLA-4 correlates with immune and clinical characteristics of glioma
Fangkun Liu et al.
CANCER CELL INTERNATIONAL (2020)
Development and validation of a 10-gene prognostic signature for acute myeloid leukaemia
Zuyi Yang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Seven genes for the prognostic prediction in patients with glioma
G. -H. Zhang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
Elevated signature of a gene module coexpressed with CDC20 marks genomic instability in glioma
Yunqiu Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Multi-study inference of regulatory networks for more accurate models of gene regulation
Dayanne M. Castro et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma
Junyu Long et al.
EBIOMEDICINE (2019)
A prognostic signature of five pseudogenes for predicting lower-grade gliomas
Bo Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
MIR155HG is a prognostic biomarker and associated with immune infiltration and immune checkpoint molecules expression in multiple cancers
Lirong Peng et al.
CANCER MEDICINE (2019)
Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
Xiangyang Deng et al.
FRONTIERS IN ONCOLOGY (2019)
A Prognostic Signature for Lower Grade Gliomas Based on Expression of Long Non-Coding RNAs
Manjari Kiran et al.
MOLECULAR NEUROBIOLOGY (2019)
An Immune-Related Signature Predicts Survival in Patients With Lung Adenocarcinoma
Minghui Zhang et al.
FRONTIERS IN ONCOLOGY (2019)
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
Zinal S. Chheda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas
Zenghui Qian et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Synergy of vaccination and agonist OX40 treatment-toward a mechanism-driven combination of glioma immunotherapy
Katrin Deumelandt et al.
NEURO-ONCOLOGY (2018)
A radiosensitivity gene signature and PD-L1 predict the clinical outcomes of patients with lower grade glioma in TCGA
Bum-Sup Jang et al.
RADIOTHERAPY AND ONCOLOGY (2018)
TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
Alice L. Hung et al.
ONCOIMMUNOLOGY (2018)
Long non-coding RNAs in brain tumours: Focus on recent epigenetic findings in glioma
Sevinci Pop et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Identification of an energy metabolism-related signature associated with clinical prognosis in diffuse glioma
Zhengui Zhou et al.
AGING-US (2018)
A nomogram-based immunoprofile predicts overall survival for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy
Jingjing Duan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Prediction of IDH1-Mutation and 1p/19q-Codeletion Status Using Preoperative MR Imaging Phenotypes in Lower Grade Gliomas
Y. W. Park et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2018)
Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base
Jiayi Huang et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Advances in the molecular genetics of gliomas - implications for classification and therapy
Guido Reifenberger et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomase
Gary Kohanbash et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Vaccine-based immunotherapeutic approaches to gliomas and beyond
Michael Weller et al.
NATURE REVIEWS NEUROLOGY (2017)
Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma
Xin Hu et al.
NEURO-ONCOLOGY (2017)
Tumor Vaccines for Malignant Gliomas
Visish M. Srinivasan et al.
NEUROTHERAPEUTICS (2017)
CRNDE Expression Positively Correlates with EGFR Activation and Modulates Glioma Cell Growth
Karrie Mei-Yee Kiang et al.
TARGETED ONCOLOGY (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas
Heather E. Leeper et al.
ONCOTARGET (2015)
The next step in brain tumor classification: Let us now praise famous men ... or molecules?
David N. Louis
ACTA NEUROPATHOLOGICA (2012)
L1 Penalized Estimation in the Cox Proportional Hazards Model
Jelle J. Goeman
BIOMETRICAL JOURNAL (2010)
1p19q LOH patterns and expression of p53 and Olig2 in gliomas: relation with histological types and prognosis
Karine S. Durand et al.
MODERN PATHOLOGY (2010)
The Guanine Nucleotide Exchange Factors Trio, Ect2, and Vav3 Mediate the Invasive Behavior of Glioblastoma
Bodour Salhia et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
